Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-18

Clinical Trial Update: Effect of Tranexamic Acid in Ruptured Abdominal Aortic Aneurysms [Phase 3]

View source ↗

Summary

Phase 3 trial update on the effect of tranexamic acid in ruptured abdominal aortic aneurysms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Saskatchewan Health Authority - Regina Area | Conditions: Abdominal Aortic Aneurysms | Phase 3 | Status: COMPLETED